BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shenvi SD, Taber DJ, Hardie AD, Botstein JO, Mcgillicuddy JW. Assessment of magnetic resonance imaging derived fat fraction as a sensitive and reliable predictor of myosteatosis in liver transplant recipients. HPB 2020;22:102-108. [DOI: 10.1016/j.hpb.2019.06.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Zeng X, Shi Z, Yu J, Wang L, Sun C, Luo Y, Shi P, Lin Y, Chen Y, Guo J, Zhang C, Xie W. Skeletal Muscle Alterations Indicate Poor Prognosis in Cirrhotic Patients: A Multicentre Cohort Study in China.. [DOI: 10.21203/rs.3.rs-2289988/v1] [Reference Citation Analysis]
2 Shafaat O, Liu Y, Jackson KR, Motter JD, Boyarsky BJ, Latif MA, Yuan F, Khalil A, King EA, Zaheer A, Summers RM, Segev DL, Mcadams-demarco M, Weiss CR. Association between Abdominal CT Measurements of Body Composition before Deceased Donor Liver Transplant with Posttransplant Outcomes. Radiology 2022. [DOI: 10.1148/radiol.212403] [Reference Citation Analysis]
3 Wang X, Sun M, Li Y, Guo G, Yang W, Mao L, Yu Z, Hui Y, Fan X, Cui B, Jiang K, Sun C. Association of myosteatosis with various body composition abnormalities and longer length of hospitalization in patients with decompensated cirrhosis. Front Nutr 2022;9. [DOI: 10.3389/fnut.2022.921181] [Reference Citation Analysis]
4 Petrič M, Jordan T, Popuri K, Ličen S, Trotovšek B, Tomažič A. WITHDRAWN: Do skeletal muscle index and myosteatosis impact postoperative outcomes after liver transplantation? Journal of Liver Transplantation 2022. [DOI: 10.1016/j.liver.2022.100106] [Reference Citation Analysis]
5 Ebadi M, Tsien C, Bhanji RA, Dunichand-Hoedl AR, Rider E, Motamedrad M, Mazurak VC, Baracos V, Montano-Loza AJ. Myosteatosis in Cirrhosis: A Review of Diagnosis, Pathophysiological Mechanisms and Potential Interventions. Cells 2022;11:1216. [PMID: 35406780 DOI: 10.3390/cells11071216] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Ahn H, Kim DW, Ko Y, Ha J, Shin YB, Lee J, Sung YS, Kim KW. Updated systematic review and meta-analysis on diagnostic issues and the prognostic impact of myosteatosis: A new paradigm beyond sarcopenia. Ageing Res Rev 2021;70:101398. [PMID: 34214642 DOI: 10.1016/j.arr.2021.101398] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 24.0] [Reference Citation Analysis]
7 Czigany Z, Kramp W, Lurje I, Miller H, Bednarsch J, Lang SA, Ulmer TF, Bruners P, Strnad P, Trautwein C, von Websky MW, Tacke F, Neumann UP, Lurje G. The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation. J Cachexia Sarcopenia Muscle 2021;12:358-67. [PMID: 33525056 DOI: 10.1002/jcsm.12669] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
8 Molinger J, Pastva AM, Whittle J, Wischmeyer PE. Novel approaches to metabolic assessment and structured exercise to promote recovery in ICU survivors. Curr Opin Crit Care 2020;26:369-78. [PMID: 32568800 DOI: 10.1097/MCC.0000000000000748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]